Managed Account Advisors’s Biogen BIIB Stock Holding History

Managed Account Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$350M	Sell	866,664 -195,721	-18%	-$78.5M	0.29%	95
2015 Q1	$449M	Buy	1,062,385 +24,829	+2%	+$9.79M	0.39%	59
2014 Q4	$352M	Sell	1,037,556 -45,427	-4%	-$14.7M	0.35%	70
2014 Q3	$358M	Buy	1,082,983 +10,878	+1%	+$3.59M	0.4%	50
2014 Q2	$338M	Sell	1,072,105 -60,176	-5%	-$18.1M	0.41%	43
2014 Q1	$346M	Sell	1,132,281 -169,349	-13%	-$53.8M	0.45%	38
2013 Q4	$364M	Sell	1,301,630 -4,208	-0.3%	-$1.09M	0.49%	31
2013 Q3	$314M	Sell	1,305,838 -278,018	-18%	-$62.2M	0.46%	35
2013 Q2	$341M	Buy	+1,583,856	New	+$338M	0.53%	28

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Managed Account Advisors's BIIB Position: Q2 2015 in Review

Managed Account Advisors reduced its Biogen (BIIB) stake by 18% in Q2 2015, selling an estimated $78.5M and leaving 866,664 shares worth $350M. The position accounts for 0.29% of the portfolio, ranked #95.

Managed Account Advisors first reported a position in BIIB in Q2 2013 and has held it in 9 quarters since. The position peaked at $449M in Q1 2015. 974 funds tracked by Wall St. Rank hold BIIB as of Q2 2015.

Managed Account Advisors held 866,664 shares of Biogen worth $350M as of Q2 2015.
Managed Account Advisors sold 195,721 Biogen shares in Q2 2015, an estimated $78.5M.
Biogen made up 0.29% of Managed Account Advisors's portfolio in Q2 2015, its #95 holding.
Managed Account Advisors first reported a position in Biogen in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Biogen position peaked at $449M in Q1 2015.
974 funds tracked by Wall St. Rank held Biogen as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.